Drugs / Campath IH
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00578266 | Feb 2007 → Aug 2016 | aplastic anemia | Mayo Clinic | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00040417 Background | Aug 2000 → Nov 2003 | sickle cell disease, thalassemia | Baylor College of Medicine | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Campath-IH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00040417 ↗ |